Tika R. Malla
Contact information
Research groups
Tika R. Malla
DPhil
Postdoctoral Scientist - Enzymology and Assay Development
Recent publications
-
In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease.
Journal article
Miura T. et al, (2023), Nat Chem, 15, 998 - 1005
-
Accelerating drug target inhibitor discovery with a deep generative foundation model.
Journal article
Chenthamarakshan V. et al, (2023), Sci Adv, 9
-
Turning high-throughput structural biology into predictive inhibitor design.
Journal article
Saar KL. et al, (2023), Proc Natl Acad Sci U S A, 120
-
Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine.
Journal article
Brewitz L. et al, (2023), J Med Chem, 66, 2663 - 2680
-
Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine.
Journal article
Malla TR. et al, (2022), J Med Chem, 65, 7682 - 7696